首頁 > 市場調查報告書 > 製藥

北美智慧生命科學製造市場預測至 2028 年 - 區域分析 - 按組件（解決方案和服務）、技術、最終用途行業（製藥、生物製藥和醫療器材）

市場調查報告書

商品編碼

1393988

北美智慧生命科學製造市場預測至 2028 年 - 區域分析 - 按組件（解決方案和服務）、技術、最終用途行業（製藥、生物製藥和醫療器材）

North America Smart Life Sciences Manufacturing Market Forecast to 2028 - Regional Analysis - by Component (Solutions and Services), Technology, End use industry (Pharma, Bio-Pharma, and Medical Device)

出版日期: 2023年10月11日 | 出版商:

The Insight Partners | 英文 176 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

北美智慧生命科學製造市場預計將從2023年的61.0189億美元成長到2033年的225.7568億美元。預計2023年至2033年CAGR為14.0%。

製藥 4.0 的採用不斷增加推動北美智慧生命科學製造市場

科技在醫療保健領域一直發揮著重要作用，其中與腫瘤學、神經學和免疫學等其他領域相比，生物技術產業是資料分析領域最新技術進步中受益最大的領域。新興資料科學技術也有助於生物技術產業的發展。生物體分析、新藥研究等是生物技術實驗室發揮的主要作用。

現代資料分析工具使生物技術研究人員能夠創建預測分析模型，並最終使他們了解實現其預期目的和目標的最有效方法。大資料、人工智慧、虛擬實境、資料視覺化和資料安全是生物技術實驗室常用的技術。 Tableau 幫助 Novozymes 將報表時間縮短了 90% 以上。它還協助公司部門內的策略決策，如銷售、原料採購、規劃和財務。此外，Tableau 還允許 Novozymes 的銷售人員與客戶分享關鍵見解，從而建立關係並提高收入績效。

阿斯特捷利康 (AstraZeneca, plc) 是一家英國-瑞典跨國製藥和生物技術公司，利用資料和技術來最大限度地縮短發現和交付潛在新藥的時間。該公司的研發部門嵌入了資料科學和人工智慧功能，使科學家能夠突破科學的界限，提供改變生活的藥物。他們將人工智慧應用於從目標識別到臨床試驗的整個發現和開發過程，以發現指導藥物發現和開發過程的新見解。 Atomwise 是一家總部位於加州的公司，也利用人工智慧來推進小分子藥物的發現。該公司與康乃狄克大學合作，與康乃狄克大學研究人員合作研究針對 COVID-19 的藥物標靶。

北美智慧生命科學製造市場概況

北美是全球已開發地區之一。由於人工智慧（AI）、物聯網（IoT）、機器學習（ML）、雲端運算和巨量資料先進技術的廣泛採用，美國在生命科學市場的智慧生命科學製造中佔據最大佔有率分析。北美地區對此類技術的採用率很高，並且有微軟公司和 IBM 公司等各種科技巨頭。這些科技公司為生命科學和醫療保健產業提供技術。此外，該地區還擁有生命科學行業的各種主要製造商，例如輝瑞（Pfizer）和通用電氣醫療保健（GE HealthCare）。這些製造商利用智慧製造技術來生產和製造藥品和醫療器材。此外，在COVID-19大流行期間，智慧製造技術的使用增加，使生產單元自動化，員工之間的接觸有限，以確保安全。例如，2019 年，Phillips 選擇 Atos 來設計和實施 IT 轉型計劃，以建立混合雲模型。該交易歷時四年半，預計將幫助飛利浦滿足客戶的需求，並提供靈活性來滿足其不斷變化的業務和技術要求。飛利浦的 IT 轉型預計將在未來幾年推動醫療保健創新。

北美智慧生命科學製造市場收入及 2033 年預測（百萬美元）

北美智慧生命科學製造市場細分

北美智慧生命科學製造市場分為技術、組件、最終用途產業和國家。

根據組件，北美智慧生命科學製造市場分為解決方案和服務。 2023年，解決方案領域在北美智慧生命科學製造市場中佔據更大佔有率。

根據技術領域分為 AR/VR 系統、物聯網 (IOT)、人工智慧 (AI)、網路安全、巨量資料等。 2023年，物聯網領域在北美智慧生命科學製造市場中佔據最大佔有率。

根據最終用途產業，北美智慧生命科學製造市場分為製藥、生物製藥和醫療器材。 2023年，醫療器材領域在北美智慧生命科學製造市場中佔據最大佔有率。

依國家/地區分類，北美智慧生命科學製造市場分為美國、加拿大和墨西哥。 2023年，美國主導北美智慧生命科學製造市場。

ABB Ltd、博世力士樂股份公司、艾默生電氣公司、Fortinet Inc、通用電氣公司、霍尼韋爾國際公司、國際商業機器公司、羅克韋爾自動化公司、西門子股份公司和Sophos Ltd 是北美智慧生活領域的一些領先公司科學製造市場。

市場促進因素
- 製藥 4.0 的採用率不斷上升
- 生物技術實驗室擴大使用技術
市場限制
- 存在技能差距和需要高額初始投資
市場機會
- 人工智慧在癌症研究的應用
- 智慧工廠採用虛擬實境
未來的趨勢
- 連接到資料孤島
- 區塊鏈的使用
- 邊緣運算
- 預測性維護
- 基於願景的品質管理
- 智慧工廠趨勢
- 工業5.0的出現
促進因素和限制因素的影響分析

第 6 章：北美智慧生命科學製造市場 - 北美分析

概述

第 7 章：北美智慧生命科學製造市場分析 - 按組成部分

概述
北美智慧生命科學製造市場，按組成部分（2022 年和 2033 年）
解決方案
服務

第 8 章：北美智慧生命科學製造市場分析 - 按技術

概述
北美智慧生命科學製造市場，按技術分類（2022 年和 2033 年）
AR/VR系統
物聯網 (IOT)
人工智慧
網路安全
巨量資料
其他

第 9 章：北美智慧生命科學製造市場分析 - 按最終用途產業

概述
北美智慧生命科學製造市場，依最終用途產業分類（2022 年和 2033 年）
製藥公司
生物製藥
醫療裝置

第 10 章：北美智慧生命科學製造市場分析 - 按國家/地區

北美：北美智慧生命科學製造市場概況

第 11 章：產業格局

概述
市場計劃、擴張和策略發展
新產品/功能開發
併購
協議、合作和合資企業

第 12 章：公司簡介

ABB Ltd
Bosch Rexroth AG
Emerson Electric Co
Fortinet Inc
General Electric Co
Honeywell International Inc
International Business Machines Corp
Rockwell Automation Inc
Siemens AG
Sophos Ltd.

第 13 章：附錄

關於 Insight Partners
詞索引

簡介目錄圖表

Product Code: BMIRE00028927

The North America Smart Life Sciences Manufacturing Market is expected to grow from US$ 6,101.89 million in 2023 to US$ 22,575.68 million by 2033. It is estimated to grow at a CAGR of 14.0% from 2023 to 2033.

Rising Adoption of Pharma 4.0 Fuel North America Smart Life Sciences Manufacturing Market

Technology has been playing a major role in the healthcare sector, wherein the biotechnology industry is the most benefited segment by recent technological advancements in data analytics, compared to other domains such as oncology, neurology, and immunology. Emerging data sciences technologies also assist in the growth of the bIoTechnology industry. The analysis of living organisms, research for novel drugs, etc., are the major roles played by bIoTechnology laboratories.

Modern data analytics tools have allowed bIoTechnology researchers to create predictive analytics models and eventually allow them to understand the most effective ways of achieving their desired goals and objectives. Big data, AI, virtual reality, data visualization, and data security are among the common technologies used in biotech laboratories. Tableau helped Novozymes cut the reporting times by more than 90%. It also assists in strategic decision-making within the company's departments such as sales, raw material purchase, +planning, and finance. In addition, Tableau allows Novozymes' sales force in sharing key insights with customers, thereby building relationships and enhancing revenue performance.

AstraZeneca, plc, a British-Swedish multinational pharmaceutical and bIoTechnology company, uses data and technology to minimize the time to discovery and delivery of potential new medicines. The company has data science and AI capabilities embedded in its R&D departments, which allows scientists to push the boundaries of science to deliver life-changing medicines. They apply AI throughout the discovery and development process, from target identification to clinical trials, to uncover new insights guiding the drug discovery and development process. Atomwise, a California-based company, also uses AI to advance small molecule drug discovery. The company partnered with Uconn to collaborate with UConn researchers on the investigation of drug targets against COVID-19.

North America Smart Life Sciences Manufacturing Market Overview

North America is one of the developed regions across the world. The US holds the largest share of the smart life sciences manufacturing in life science market owing to high adoption of advance technologies such as artificial intelligence (AI), Internet of Things (IoT), machine learning (ML), cloud computing, and big data analytics. The North American region has high adoption of such technologies along with the presence of various tech giants such as Microsoft Corporation and IBM Corporation. These tech companies provide technologies to the life sciences & healthcare industry. Additionally, the region houses various major manufacturers from the life science industry such as Pfizer and GE HealthCare. These manufacturers use smart manufacturing technologies to produce and manufacture pharmaceutical and medical devices. Moreover, during COVID-19 pandemic, the use of smart manufacturing technologies increased to automate the production units with limited contact among employees to ensure safety. For instance, in 2019 Phillips selected Atos to design and implement an IT transformation program to build a hybrid cloud model. The deal was done for four and a half years and is expected to help Philips in meeting the needs of their customers and provides flexibility to meet its evolving business and technology requirements. The IT transformation of Phillips is expected to drive healthcare innovation in the coming years.

North America Smart Life Sciences Manufacturing Market Revenue and Forecast to 2033 (US$ Million)

North America Smart Life Sciences Manufacturing Market Segmentation

The North America smart life sciences manufacturing market is segmented into technology, component, end use industry, and country.

Based on component, the North America smart life sciences manufacturing market is segmented into solutions and services. The solution segment held a larger share of the North America smart life sciences manufacturing market in 2023.

Based on technology segment is categorized into AR/VR Systems, Internet of things (IOT), Artificial Intelligence (AI), Cybersecurity, Big Data, and others. The Internet of things segment held the largest share of the North America smart life sciences manufacturing market in 2023.

Based on end use industry, the North America smart life sciences manufacturing market is segmented into pharma, bio-pharma, and medical devices. The medical device segment held the largest share of the North America smart life sciences manufacturing market in 2023.

Based on country, the North America smart life sciences manufacturing market is segmented into the US, Canada, and Mexico. The US dominated the North America smart life sciences manufacturing market in 2023.

ABB Ltd, Bosch Rexroth AG, Emerson Electric Co, Fortinet Inc, General Electric Co, Honeywell International Inc, International Business Machines Corp, Rockwell Automation Inc, Siemens AG, and Sophos Ltd are some of the leading companies operating in the North America smart life sciences manufacturing market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America Smart Life Sciences Manufacturing Market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in North America Smart Life Sciences Manufacturing Market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth North America Market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 North America Smart Life Sciences Manufacturing Market - By Component
- 1.3.2 North America Smart Life Sciences Manufacturing Market - By Technology
- 1.3.3 North America Smart Life Sciences Manufacturing Market - By End Use Industry
- 1.3.4 North America Smart Life Sciences Manufacturing Market - By Country

2. North America Smart Life Sciences Manufacturing Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Smart Life Sciences Manufacturing Market - Market Landscape

4.1 Overview
4.2 North America PEST Analysis
4.3 Ecosystem Analysis
4.4 Expert Opinion

5. North America Smart Life Sciences Manufacturing Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Rising Adoption of Pharma 4.0
- 5.1.2 Increasing Use of Technologies in Biotechnology Laboratories
5.2 Market Restraints
- 5.2.1 Presence of Skill Gap and Need for High Initial Investment
5.3 Market Opportunities
- 5.3.1 Use of Artificial Intelligence in Cancer Research
- 5.3.2 Adoption of Virtual Reality in Smart Factory
5.4 Future Trends
- 5.4.1 Connection to Data Silos
- 5.4.2 Usage of Blockchain
- 5.4.3 Edge Computing
- 5.4.4 Predictive Maintenance
- 5.4.5 Vision-Based Quality Management
- 5.4.6 Smart Factory Trends
- 5.4.7 Emergence of Industry 5.0
5.5 Impact Analysis of Drivers and Restraints

6. North America Smart Life Sciences Manufacturing Market - North America Analysis

6.1 Overview
6.2 North America Smart Life Sciences Manufacturing Market - Revenue and Forecast to 2033 (US$ Million)

7. North America Smart Life Sciences Manufacturing Market Analysis - By Component

7.1 Overview
7.2 North America Smart Life Sciences Manufacturing Market, By Component (2022 and 2033)
7.3 Solutions
- 7.3.1 Overview
- 7.3.2 Solutions: North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
7.4 Services
- 7.4.1 Overview
- 7.4.2 Services: North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)

8. North America Smart Life Sciences Manufacturing Market Analysis - By Technology

8.1 Overview
8.2 North America Smart Life Sciences Manufacturing Market, By Technology (2022 and 2033)
8.3 AR/VR System
- 8.3.1 Overview
- 8.3.2 AR/VR System: North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
8.4 Internet of Things (IOT)
- 8.4.1 Overview
- 8.4.2 Internet of Things (IOT): North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
8.5 Artificial Intelligence
- 8.5.1 Overview
- 8.5.2 Artificial Intelligence: North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
8.6 Cyber Security
- 8.6.1 Overview
- 8.6.2 Cyber Security: North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
8.7 Big Data
- 8.7.1 Overview
- 8.7.2 Big Data: North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
8.8 Others
- 8.8.1 Overview
- 8.8.2 Others: North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)

9. North America Smart Life Sciences Manufacturing Market Analysis - By End Use Industry

9.1 Overview
9.2 North America Smart Life Sciences Manufacturing Market, by End Use Industry (2022 and 2033)
9.3 Pharma
- 9.3.1 Overview
- 9.3.2 Pharma: North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
9.4 Bio-Pharma
- 9.4.1 Overview
- 9.4.2 Bio-Pharma: North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
9.5 Medical Device
- 9.5.1 Overview
- 9.5.2 Medical Device: North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)

10. North America Smart Life Sciences Manufacturing Market Analysis - By Country

10.1 North America: North America Smart Life Sciences Manufacturing Market Overview

11. Industry Landscape

11.1 Overview
11.2 Market Initiatives, Expansions, and Strategic Developments
11.3 New Product/Feature Development
11.4 Mergers and Acquisitions
11.5 Agreements, Collaborations, and Joint Ventures

12. Company Profile

12.1 ABB Ltd
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Bosch Rexroth AG
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Emerson Electric Co
- 12.3.1 Business Description
- 12.3.2 Products and Services
- 12.3.3 Financial Overview
- 12.3.4 SWOT Analysis
- 12.3.5 Key Developments
12.4 Fortinet Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 General Electric Co
- 12.5.1 Business Description
- 12.5.2 Products and Services
- 12.5.3 Financial Overview
- 12.5.4 SWOT Analysis
- 12.5.5 Key Developments
12.6 Honeywell International Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 International Business Machines Corp
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Rockwell Automation Inc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Siemens AG
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Sophos Ltd.
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Word Index

簡介目錄圖表

List Of Tables

Table 1. North America Smart Life Sciences Manufacturing Market - Revenue and Forecast to 2033 (US$ Million)
Table 2. US North America Smart Life Sciences Manufacturing Market, by Component - Revenue and Forecast to 2033 (US$ Million)
Table 3. US North America Smart Life Sciences Manufacturing Market, by Technology - Revenue and Forecast to 2033 (US$ Million)
Table 4. US North America Smart Life Sciences Manufacturing Market, Cybersecurity by Type - Revenue and Forecast to 2033 (US$ Million)
Table 5. US North America Smart Life Sciences Manufacturing Market, by End Use Industry - Revenue and Forecast to 2033 (US$ Million)
Table 6. Canada North America Smart Life Sciences Manufacturing Market, by Component - Revenue and Forecast to 2033 (US$ Million)
Table 7. Canada North America Smart Life Sciences Manufacturing Market, by Technology - Revenue and Forecast to 2033 (US$ Million)
Table 8. Canada North America Smart Life Sciences Manufacturing Market, Cybersecurity by Type - Revenue and Forecast to 2033 (US$ Million)
Table 9. Canada North America Smart Life Sciences Manufacturing Market, by End Use Industry - Revenue and Forecast to 2033 (US$ Million)
Table 10. Mexico North America Smart Life Sciences Manufacturing Market, by Component - Revenue and Forecast to 2033 (US$ Million)
Table 11. Mexico North America Smart Life Sciences Manufacturing Market, by Technology - Revenue and Forecast to 2033 (US$ Million)
Table 12. Mexico North America Smart Life Sciences Manufacturing Market, Cybersecurity by Type - Revenue and Forecast to 2033 (US$ Million)
Table 13. Mexico North America Smart Life Sciences Manufacturing Market, by End Use Industry - Revenue and Forecast to 2033 (US$ Million)
Table 14. List of Abbreviation

List Of Figures

Figure 1. North America Smart Life Sciences Manufacturing Market Segmentation
Figure 2. North America Smart Life Sciences Manufacturing Market Segmentation, By Country
Figure 3. North America Smart Life Sciences Manufacturing Market Overview
Figure 4. Solutions Held Largest Share of Component Segment in North America Smart Life Sciences Manufacturing Market
Figure 5. North America Region Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. North America: PEST Analysis
Figure 7. Expert Opinion
Figure 1. North America Smart Life Sciences Manufacturing Market: Impact Analysis of Drivers and Restraints
Figure 2. North America Smart Life Sciences Manufacturing Market - Revenue and Forecast to 2033 (US$ Million)
Figure 3. North America Smart Life Sciences Manufacturing Market Revenue Share, By Component (2022 and 2033)
Figure 4. Solutions: North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
Figure 5. Services: North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
Figure 6. North America Smart Life Sciences Manufacturing Market Revenue Share, By Technology (2022 and 2033)
Figure 7. AR/VR System: North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
Figure 8. Internet of Things (IOT): North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
Figure 9. Artificial Intelligence: North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
Figure 10. Cyber Security: North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
Figure 11. Big Data: North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
Figure 12. Others: North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
Figure 13. North America Smart Life Sciences Manufacturing Market Revenue Share, By End Use Industry (2022 and 2033)
Figure 14. Pharma: North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
Figure 15. Bio-Pharma : North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
Figure 16. Medical Device: North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
Figure 17. North America Smart Life Sciences Manufacturing Market, by Key Country - Revenue (2022) (US$ Million)
Figure 18. North America Smart Life Sciences Manufacturing Market Revenue Share, by Key Country, (2022 & 2033)
Figure 19. US: North America Smart Life Sciences Manufacturing Market - Revenue and Forecast to 2033 (US$ Million)
Figure 20. Canada: North America Smart Life Sciences Manufacturing Market - Revenue and Forecast to 2033 (US$ Million)
Figure 21. Mexico: North America Smart Life Sciences Manufacturing Market - Revenue and Forecast to 2033 (US$ Million)